Medical device manufacturing company RemSleep Holdings Inc (OTCMKTS:RMSL) is working on transforming the treatment that is available to patients who suffer from obstructive sleep apnea. The RemSleep stock was in significant focus among investors yesterday and ended the day with gains of as much as 34%.
Trading Data
On Tuesday, RMSL stock surged 34.17% to $0.0267 with 61.92 million share, compared to its average volume of 16.51 million shares. The stock has moved within a range of $0.0199 – 0.0269 after opening trade at $0.0214.
RemSleep Holdings Inc Announces Engagement of New Investor Relations Firm and News Distributor
In light of such significant gains, it may be a good idea to perhaps take a closer look at the announcement made by the company on Monday. The company announced at the time that it had decided to go into a partnership with MCAP Mediawire and Preya Co for investor communication services.
RemSleep noted that the communication services that are going to be provided by the two firms are going to be important for not only keeping an open line of communication with existing shareholders, but also attract potential investors.
Such communication expertise is necessary for all companies and it seems that the step taken by RemSleep has come as a source of encouragement for investors as well. The rally in the stock continued until yesterday and it is now going to be interesting to see if it can manage to hold on to its momentum through the rest of the week and beyond.
Technical Data
RMSL stock is trading above the 20-Day and 50-Day Moving averages of $0.0176 and $0.0149 respectively. Moreover, the stock is trading above the 200-Day moving average of $0.0164.